CDMO — Avid Bioservices Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for Avid Bioservices, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2020 April 30th	2021 April 30th	2022 April 30th	2023 April 30th	2024 April 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K/A	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	59.7	95.9	120	149	140
Cost of Revenue
Gross Profit	3.93	29.3	36.6	31.5	7.32
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses	70.6	83.6	104	146	160
Operating Profit	-10.9	12.2	15.4	3.6	-20.6
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-10.5	11.2	12.7	1.59	-26.9
Provision for Income Taxes
Net Income After Taxes	-10.5	11.2	128	0.259	-141
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-10.5	11.2	128	0.259	-141
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-15.2	3.32	130	0.259	-141
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.263	0.056	1.84	0.004	-2.21